Taking into consideration our finding that estrogen promotes EMT, proliferation, sphere-forming potential, and Akt activation in Brca1-deficient tumor cells in vitro, these results suggest that host estrogen likely promotes Brca1-deficient tumor initiation, which support our conclusion. The gene discussed is BRCA1; the disease is neoplasm.